Figure 14 . (A) The control group was injected with an equal amount of sterile PBS intraperitoneally. (B) The LPS group was the model group, and 10 mg/kg LPS solution was injected intraperitoneally. (C) The LPS+Tube group was the Tube group treated with 10 mg/kg LPS solution for 3 hours after intraperitoneal injection of 1 mg/kg Tube. (D) The Tube+Citra group was the inhibitor group, with an intraperitoneal injection of citraconate and Tube, followed by 10 mg/kg LPS solution after 3 hours.